Academic Heart Failure Transplant 
DAIC
FEBRUARY 22, 2024
The inherited heart condition often goes undiagnosed until it advances to heart failure, which is why it’s important to identify those at risk and begin treatment early. Hershberger leads the DCM Consortium , which is composed of 25 leading academic U.S. Eventually heart failure may develop, which is late-phase disease.
Dr. S. Venkatesan MD
OCTOBER 26, 2024
Which is more often not the case) Unfortunately, while technology allow us to replace a defective valve or even transplant a entire heart. At best, we can try stimulating the heart it two or three sites. There is less compelling academic reasons for this change, than we think.
Cardiology Update
APRIL 9, 2024
Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes.
Cardiometabolic Health Congress
MARCH 8, 2024
Anuradha Lala-Trindade, MD: She focuses on the selection and care of patients with mechanical circulatory support devices and heart transplantation, genetic cardiomyopathies, and perioperative management of high-risk cardiac surgical cases. A framework for mentor-mentees can help promote and retain women in academic medicine.
Dr. Malcolm Kendrick
OCTOBER 30, 2024
At one point George Mann attempted to arrange a meeting of scientists who agreed that the diet-heart/cholesterol hypothesis was bunk. I believe you are right, and that the diet-heart hypothesis is wrong, but I cannot join you, for that would jeopardize my perks and funding. SEARCH trial of simvastatin dose (1997-2010) Merck: £22.7M
Expert insights. Personalized for you.
104 
Let's personalize your content